⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16288003 | 0.90 | — | — | |
| SCHEMBL1352530 | 0.85 | — | — | |
| SCHEMBL2848183 | 0.82 | — | — | |
| SCHEMBL6124696 | 0.80 | — | — | |
| Hydrochloric Acid SCHEMBL7962177 | 0.79 | EPHX1 (0.35) | — | |
| Bromide SCHEMBL1394599 | 0.79 | EPHX1 (0.35) | — | |
| SCHEMBL10626682 | 0.79 | — | — | |
| SCHEMBL16259516 | 0.79 | — | — | |
| Water SCHEMBL10625822 | 0.77 | EPHX1 (0.33) | — | |
| SCHEMBL11604099 | 0.77 | EPHX1 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12485109-B2 | Pyrrolo 12.3-dipyrimidine compounds and analogues thereof | BIOCRYST PHARMACEUTICALS, INC. (US) | 2025-12-02 | — | — | US | disclosed |
| US-20250332138-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING MENTAL DISORDER | VIVOZON, INC. (KR) | 2025-10-30 | — | — | US | disclosed |
| US-12435051-B2 | Dual modulator of mGluR5 and 5-HT2A receptor, and use thereof | VIVOZON, INC. (KR) | 2025-10-07 | — | — | US | disclosed |
| US-20250034165-A1 | COMPOUND CONTAINING CYCLOALKYL OR HALOALKYL | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. (CN) | 2025-01-30 | — | — | US | disclosed |
| EP-4470534-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING MENTAL DISORDER | Vivozon, Inc. (KR) | 2024-12-04 | — | — | EP | disclosed |
| US-20240360092-A1 | DUAL MODULATOR OF MGLUR5 AND 5-HT2A RECEPTOR, AND USE THEREOF | VIVOZON INC. (KR) | 2024-10-31 | — | — | US | disclosed |
| EP-4442690-A1 | COMPOUND CONTAINING CYCLOALKYL OR HALOALKYL | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) | 2024-10-09 | — | — | EP | disclosed |
| US-12060339-B2 | Dual modulator of mGluR5 and 5-HT2A receptor, and use thereof | VIVOZON INC. (KR) | 2024-08-13 | — | — | US | disclosed |
| EP-3925956-B1 | 1H-INDAZOLE-3-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS FACTOR D INHIBITORS FOR TREATING DISEASES CHARACTERIZED BY ABERRANT COMPLEMENT SYSTEM ACTIVITY, SUCH AS E.G. IMMUNOLOGICAL DISORDERS | BIOCRYST PHARM INC (US) | 2024-04-10 | — | — | EP | disclosed |
| WO-2023146291-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING MENTAL DISORDER | 주식회사 비보존 | 2023-08-03 | — | — | WO | disclosed |
| EP-2847177-A1 | METHODS FOR MAKING OXETAN-3-YLMETHANAMINES | Boehringer Ingelheim International GmbH (DE) | 2015-03-18 | — | — | EP | disclosed |
| WO-2015013396-A1 | CROSS-LINKABLE FLUORINATED PHOTOPOLYMER | ORTHOGONAL, INC. (US) | 2015-01-29 | — | — | WO | disclosed |
| US-20140349987-A1 | PYRROLO CARBOXAMIDES AS MODULATORS OF ORPHAN NUCLEAR RECEPTOR RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORy, NR1F3) ACTIVITY AND FOR THE TREATMENT OF CHRONIC INFLAMMATORY AND AUTOIMMUNE DISEASES | PHENEX PHARMACEUTICALS AG (DE) | 2014-11-27 | — | — | US | disclosed |
| WO-2014039412-A1 | PYRROLONE OR PYRROLIDINONE MELANIN CONCENTRATING HORMONE RECEPTOR-1 ANTAGONISTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2014-03-13 | — | — | WO | disclosed |
| WO-2013169531-A1 | METHODS FOR MAKING OXETAN-3-YLMETHANAMINES | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2013-11-14 | — | — | WO | disclosed |
| US-8487099-B2 | Gamma secretase modulators | MERCK SHARP & DOHME CORP. (US) | 2013-07-16 | — | — | US | disclosed |
| WO-2013053658-A1 | COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS DISEASE | F. HOFFMANN-LA ROCHE AG (CH) | 2013-04-18 | — | — | WO | disclosed |
| US-20130090328-A1 | COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS DISEASE | Hoffmann-La Roche Inc (US) | 2013-04-11 | — | — | US | disclosed |
| US-20120107328-A1 | GAMMA SECRETASE MODULATORS | MERCK SHARP & DOHME CORP. | 2012-05-03 | — | — | US | disclosed |
| EP-1834969-A2 | Curable materials containing siloxane | National Starch and Chemical Investment Holding Corporation (US) | 2007-09-19 | — | — | EP | disclosed |